Home
HLS Therapeutics

HLS Therapeutics Market Share Analysis for August 2026

learn more about us.

Industry: N/A

Domainhlstherapeutics.com

Year Founded2014

Employees51 - 200

Annual Revenue$50M - $75M

HLS Therapeutics

HLS Therapeutics (including company regionals)

hlstherapeutics.com

See more website traffic and engagement information

HLS Therapeutics Revenue up to August 2026 is 50M - 75M

revenue generated by HLS Therapeutics top domains

HLS Therapeutics top domains revenue over 3 years

Revenue for HLS Therapeutics top domains

hlstherapeutics.com50M - 75M

See more with Sales Intelligence

Total visits to HLS Therapeutics's top domains

Understand HLS Therapeutics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

hlstherapeutics.com3.2K

See more with Sales Intelligence

Avg. visit duration in HLS Therapeutics's top domains

Analyze HLS Therapeutics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

hlstherapeutics.com00:00:17

See more with Sales Intelligence

Avg. pageviews on HLS Therapeutics's top domains

See how HLS Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

hlstherapeutics.com1.65

See more with Sales Intelligence

HLS Therapeutics top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by HLS Therapeutics

These are the website technologies, by industry, used by HLS Therapeutics top domains

Widget (3)

Twemoji

Advertising (2)

DoubleClick

Content Management System (2)

WordPress

Mobile (2)

Meta Viewport

More Technologies

6

See all

News & Signals from HLS Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsHLS Therapeutics Inc. appoints Mark DeLong as an independent director in Canada on Oct 1st '26TORONTO, Oct. 1, 2026 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS) announces the appointment of Linda Maxwell, M.D. and Mark DeLong as independent directors to its Board of Directors (the "Board"), effective today.

NewsHLS Therapeutics Inc. attended event 2026 Bloom Burton & Co. Healthcare Investor Conference on Apr 21st '22TORONTO, April 14, 2026 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a pharmaceutical company focused on addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease, announces that Craig Millian, Chief Executive Officer, will present at the 2026 Bloom Burton & Co. Healthcare Investor Conference, which takes place April 21-22, 2026 at the Metro Toronto Convention Centre, in downtown Toronto.